13 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain regulatory approval to market our product
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
litigation, require us to pay substantial amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain
424B5
a3ijaa55x
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
2a3dt3r4zm8
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
qqf02
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
dg4hf3ibs31
8 Nov 22
Quarterly report
4:09pm
424B5
8je7 fzm6u6e
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
sftjw0gs uj7
13 Oct 22
Prospectus supplement for primary offering
4:56pm
- Prev
- 1
- Next